Company News
Dr. Reddy’s Posts Consolidated Loss Of Rs. 569.7 Crores In Q3 FY20
DR.REDDY’s LABORATORIES LTD. has reported financial results for the period ended December 31, 2019.
Financial Results (Q3 FY19-20) – QoQ Comparison
The company has reported net sales of Rs.4383.8 crores during the period ended December 31, 2019 as compared to Rs.4800.9 crores during the period ended September 30, 2019.
The company has posted net loss of Rs.(569.7) crores for the period ended December 31, 2019 as against net profit of Rs.1092.5 crores for the period ended September 30, 2019.
The company has reported EPS of Rs.(34.37) for the period ended December 31, 2019 as compared to Rs.65.82 for the period ended September 30, 2019.
| Financials | Q3 FY19-20 | Q2 FY19-20 | % Change |
| Total Income | ₹ 4383.8 crs | ₹ 4800.9 crs |  -8.69% |
| Net Profit | ₹ (569.7) crs | ₹ 1092.5 crs | -152.15% |
| EPS | ₹ (34.37) | ₹ 65.82 | -152.22% |
Financial Results (Q3 FY19-20) – YoY Comparison
The company has reported net sales of Rs.4383.8 crores during the period ended December 31, 2019 as compared to Rs.3850 crores during the period ended December 31, 2018.
The company has posted net loss of Rs.(569.7) crores for the period ended December 31, 2019 as against net profit of Rs.485.2 crores for the period ended December 31, 2018.
The company has reported EPS of Rs.(34.37) for the period ended December 31, 2019 as compared to Rs.29.21 for the period ended December 31, 2018.
| Financials | Q3 FY19-20 | Q3 FY18-19 | % Change |
| Total Income | ₹ 4383.8 crs | ₹ 3850 crs |  13.86% |
| Net Profit | ₹ (569.7) crs | ₹ 485.2 crs | -217.42% |
| EPS | ₹ (34.37) | ₹ 29.21 | -217.67% |
Financial Results (9 months ended FY 19-20) – YoY Comparison
The company has reported net sales of Rs.13028.2 crores during the 9 months period ended December 31, 2019 as compared to Rs.11368.5 crores during the 9 months period ended December 31, 2018.
The company has posted net profit of Rs.1185.6 crores for the 9 months period ended December 31, 2019 as against Rs.1445.1 crores for the 9 months period ended December 31, 2018.
The company has reported EPS of Rs.71.40 for the 9 months period ended December 31, 2019 as compared to Rs.86.97 for the 9 months period ended December 31, 2018.
| Financials | 9 months FY19-20 | 9 months FY18-19 | % Change |
| Total Income | ₹ 13028.2 crs | ₹ 11368.5 crs | 14.6% |
| Net Profit | ₹ 1185.6 crs | ₹ 1445.1 crs | -17.96% |
| EPS | ₹ 71.40 | ₹86.97 | -17.9% |
Shares of DR.REDDY’s LABORATORIES LTD. was last trading in BSE at Rs.3028.05 as compared to the previous close of Rs. 3038.45. The total number of shares traded during the day was 3562 in over 524 trades.
The stock hit an intraday high of Rs. 3046.7 and intraday low of 3025.45. The net turnover during the day was Rs. 10811221.-Equity Bulls
